Pharmaceuticals is the largest segment driving the growth of Bacillus Coagulans Market
![]() |
Bacillus Coagulans Market |
The global Bacillus Coagulans Market is estimated to be valued at US$ 722.43 Mn in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Bacillus Coagulans is a type of probiotic bacteria found in the intestines and gut. Products containing Bacillus Coagulans provide benefits like maintaining digestive health, supporting immune function, and managing lactose intolerance.
Market key trends:
One of the major trends in the
Bacillus Coagulans market is the increasing demand for probiotic dietary
supplements. Consumers are more aware now about gut and total body health.
Probiotic supplements are considered an effective natural remedy to improve
digestive health, boost immunity, and manage various gut related conditions
like IBS without any side effects. This has propelled the demand for Bacillus
Coagulans in dietary supplements globally. The growing demand for natural
health products is expected to drive the growth of the Bacillus Coagulans
market during the forecast period.
Segment Analysis
The global Bacillus Coagulans market is segmented into drug formulations, probiotic supplements, and food & beverages. Among these, the probiotic supplements segment accounted for the largest market share of over 35% in 2022. Probiotic supplements provide numerous health benefits such as improved digestion, immunity and gut health. Growing awareness about preventive healthcare is driving the growth of this segment.
Key Takeaways
The global Bacillus Coagulans market is expected to witness high growth, exhibiting CAGR of 6.8% over the forecast period, due to increasing awareness about probiotic health benefits.
Regional analysis:
North America dominated the Bacillus Coagulans market in 2022 and accounted for over 30% of the global market share. This is attributed to rising health concerns and increased spending on probiotic supplements in the region. Asia Pacific is expected to be the fastest growing market during the forecast period owing to growing middle class population and their increasing disposable income in the region.
Key players:
Key players operating in the Bacillus Coagulans market are Ganeden, Sabinsa Corporation, UAS Laboratories, Sanzyme, Mitsubishi Chemical Foods Corporation, Mystical Biotech Pvt. Ltd., Aumgene Biosciences, Unique Biotech Ltd., Nebraska Culture, and Syngem Biotech. Ganeden and Sabinsa Corporation collectively accounted for over 25% of the global market share in 2022.
Read More
https://www.dailyprbulletin.com/bacillus-coagulans-market-size-share-growth-outlook-2023/
Comments
Post a Comment